Noninvasive prenatal testing for congenital heart disease – cell-free nucleic acid and protein biomarkers in maternal blood

References

• Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart disease and stroke statistics—2017 update: a report from the American Heart Association. Circulation. 2017;135:e146–ee603.
   PubMed Web of Science ®Google Scholar
• Gilboa SM, Salemi JL, Nembhard WN, et al. Mortality resulting from congenital heart disease among children and adults in the United States, 1999–2006. Circulation. 2010;122:2254–2263.
   PubMed Web of Science ®Google Scholar
• Dearani JA, Mavroudis C, Quintessenza J, et al. Surgical advances in the treatment of adults with congenital heart disease. Curr Opin Pediatr. 2009;21:565–572.
   PubMed Web of Science ®Google Scholar
• Nelle M, Raio L, Pavlovic M, et al. Prenatal diagnosis and treatment planning of congenital heart defects – possibilities and limits. World J Pediatr. 2009;5:18–22.
   PubMed Web of Science ®Google Scholar
• Bonnet D, Coltri A, Butera G, et al. Detection of transposition of the great arteries in fetuses reduces neonatal morbidity and mortality. Circulation. 1999;99:916–918.
   PubMed Web of Science ®Google Scholar
• Tworetzky W, McElhinney DB, Reddy VM, et al. Improved surgical outcome after fetal diagnosis of hypoplastic left heart syndrome. Circulation. 2001;103:1269–1273.
   PubMed Web of Science ®Google Scholar
• Franklin O, Burch M, Manning N, et al. Prenatal diagnosis of coarctation of the aorta improves survival and reduces morbidity. Heart. 2002;87:67–69.
   PubMed Web of Science ®Google Scholar
• Hunter LE, Simpson JM. Prenatal screening for structural congenital heart disease. Nat Rev Cardiol. 2014;11:323–334.
   PubMed Web of Science ®Google Scholar
• Jenkins KJ, Correa A, Feinstein JA, et al. Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation. 2007;115:2995–3014.
   PubMed Web of Science ®Google Scholar
• Nayak K, Chandra GSN, Shetty R, et al. Evaluation of fetal echocardiography as a routine antenatal screening tool for detection of congenital heart disease. CardioVasc Diagn Ther. 2016;6:44–49.
   PubMed Web of Science ®Google Scholar
• Swarup V, Rajeswari MR. Circulating (cell-free) nucleic acids – a promising, non-invasive tool for early detection of several human diseases. FEBS Lett. 2007;581:795–799.
   PubMed Web of Science ®Google Scholar
• van der Vaart M, Pretorius PJ. The origin of circulating free DNA. Clin Chem. 2007;53:2215.
   PubMed Web of Science ®Google Scholar
• Lo YM, Tein MS, Lau TK, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet. 1998;62:768–775.
   PubMed Web of Science ®Google Scholar
• Turchinovich A, Cho WC. The origin, function and diagnostic potential of extracellular microRNA in human body fluids. Front Genet. 2014;5:30.
   PubMed Web of Science ®Google Scholar
• Richards AA, Garg V. Genetics of congenital heart disease. Curr Cardiol Rev. 2010;6:91–97.
   PubMedGoogle Scholar
• Srinivasan A, Bianchi DW, Huang H, et al. Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma. Am J Hum Genet. 2013;92:167–176.
   PubMed Web of Science ®Google Scholar
• Wapner RJ, Babiarz JE, Levy B, et al. Expanding the scope of noninvasive prenatal testing: detection of fetal microdeletion syndromes. Am J Obstet Gynecol. 2015;212:332.e1–332.e9.
   Web of Science ®Google Scholar
• Korenberg JR, Chen XN, Schipper R, et al. Down syndrome phenotypes: the consequences of chromosomal imbalance. Proc Natl Acad Sci USA. 1994;91:4997–5001.
   PubMed Web of Science ®Google Scholar
• Springett A, Wellesley D, Greenlees R, et al. Congenital anomalies associated with trisomy 18 or trisomy 13: a registry-based study in 16 European countries, 2000–2011. Am J Med Genet. 2015;167: 3062–3069.
   Web of Science ®Google Scholar
• Farina A, Volinia S, Arcelli D, et al. Evidence of genetic underexpression in chorionic villi samples of euploid fetuses with increased nuchal translucency at 10–11 weeks’ gestation. Prenat Diagn. 2006;26:128–133.
   PubMed Web of Science ®Google Scholar
• Arcelli D, Farina A, Cappuzzello C, et al. Identification of circulating placental mRNA in maternal blood of pregnancies affected with fetal congenital heart diseases at the second trimester of pregnancy: implications for early molecular screening. Prenat Diagn. 2010;30:229–234.
   PubMed Web of Science ®Google Scholar
• Curti A, Lapucci C, Berto S, et al. Maternal plasma mRNA species in fetal heart defects: a potential for molecular screening. Prenat Diagn. 2016;36:738–743.
   PubMed Web of Science ®Google Scholar
• Liu N, Olson EN. MicroRNA regulatory networks in cardiovascular development. Dev Cell. 2010;18:510–525.
   PubMed Web of Science ®Google Scholar
• Condorelli G, Latronico MVG, Cavarretta E. MicroRNAs in cardiovascular diseases: current knowledge and the road ahead. J Am Coll Cardiol. 2014;63:2177–2187.
   PubMed Web of Science ®Google Scholar
• Xie WQ, Zhou L, Chen Y, et al. Circulating microRNAs as potential biomarkers for diagnosis of congenital heart defects. World J Emerg Med. 2016;7:85–89.
   PubMed Web of Science ®Google Scholar
• Turchinovich A, Samatov TR, Tonevitsky AG, et al. Circulating miRNAs: cell–cell communication function? Front Genet. 2013;4:119.
   PubMedGoogle Scholar
• Yu Z, Han S, Hu P, et al. Potential role of maternal serum microRNAs as a biomarker for fetal congenital heart defects. Med Hypotheses. 2011;76:424–426.
   PubMed Web of Science ®Google Scholar
• Zhu S, Cao L, Zhu J, et al. Identification of maternal serum microRNAs as novel non-invasive biomarkers for prenatal detection of fetal congenital heart defects. Clin Chim Acta. 2013;424:66–72.
   PubMed Web of Science ®Google Scholar
• Kehler L, Biro O, Lazar L, et al. Elevated hsa-miR-99a levels in maternal plasma may indicate congenital heart defects. Biomed Rep. 2015;3:869–873.
   PubMed Web of Science ®Google Scholar
• Coppola A, Romito A, Borel C, et al. Cardiomyogenesis is controlled by the miR-99a/let-7c cluster and epigenetic modifications. Stem Cell Res. 2014;12:323–337.
   PubMed Web of Science ®Google Scholar
• Lázár L, Biró O, Rigó JJ, et al. Let-7c as potential maternal serum miRNA biomarker in fetal congenital heart defects. Biomed Pap. 2014;158:S8.
   Google Scholar
• Scheuermann JC, Boyer LA. Getting to the heart of the matter: long non-coding RNAs in cardiac development and disease. Embo J. 2013;32:1805–1816.
   PubMed Web of Science ®Google Scholar
• He C, Hu H, Wilson KD, et al. Systematic characterization of long noncoding RNAs reveals the contrasting coordination of cis- and trans-molecular regulation in human fetal and adult hearts. Circ Cardiovasc Genet. 2016;9:110–118.
   PubMed Web of Science ®Google Scholar
• Song G, Shen Y, Zhu J, et al. Integrated analysis of dysregulated lncRNA expression in fetal cardiac tissues with ventricular septal defect. PLoS One. 2013;8:e77492.
   PubMed Web of Science ®Google Scholar
• Gu M, Zheng A, Tu W, et al. Circulating LncRNAs as novel, non-invasive biomarkers for prenatal detection of fetal congenital heart defects. Cell Physiol Biochem. 2016;38:1459–1471.
   PubMed Web of Science ®Google Scholar
• Llurba E, Syngelaki A, Sánchez O, et al. Maternal serum placental growth factor at 11–13 weeks’ gestation and fetal cardiac defects. Ultrasound Obstet Gynecol. 2013;42:169–174.
   PubMed Web of Science ®Google Scholar
• Llurba E, Sánchez O, Ferrer Q, et al. Maternal and foetal angiogenic imbalance in congenital heart defects. Eur Heart J. 2014;35:701–707.
   PubMed Web of Science ®Google Scholar
• Curti A, Zucchini C, De Maggio I, et al. Fetal cardiac defects and third-trimester maternal serum placental growth factor. Ultrasound Obstet Gynecol. 2015;45:751–752.
   PubMed Web of Science ®Google Scholar
• Chen L, Gu H, Li J, et al. Comprehensive maternal serum proteomics identifies the cytoskeletal proteins as non-invasive biomarkers in prenatal diagnosis of congenital heart defects. Sci Rep. 2016;6:19248.
   PubMed Web of Science ®Google Scholar
• Farina A, Arcelli D. Congenital heart defects: is it time to explore maternal blood for a non-invasive genetic screening test? Ultrasound Obstet Gynecol. 2014;43:109–110.
   PubMed Web of Science ®Google Scholar
• Boyd HA, Basit S, Behrens I, et al. Association between fetal congenital heart defects and maternal risk of hypertensive disorders of pregnancy in the same pregnancy and across pregnancies clinical. Circulation. 2017;136:39–48.
   PubMed Web of Science ®Google Scholar
• Lalani SR. Other genomic disorders causing congenital cardiovascular malformations. In: Muenke M, Kruszka PS, Sable CA, Belmont JW, editors. Congenital heart disease: molecular genetics, principles of diagnosis and treatment. Basel: S. Karger AG; 2015. p. 112–120.
   Google Scholar
• The NIFTY® Test – non-invasive prenatal testing by BGI. [Internet]. 2018 [cited 2018 Jul 13]. Available from: https://www.bgi.com/global/molecular-genetics/nifty-non-invasive-prenatal-testing/the-nifty-test-non-invasive-prenatal-testing/.
   Google Scholar
• MaterniT® – non-invasive prenatal testing by Sequenom. [Internet]. 2018 [cited 2018 Jul 13]. Available from: https://www.sequenom.com/videos/what-is-noninvasive-prenatal-testing-nipt.
   Google Scholar
• Panorama® Test – non-invasive prenatal testing by NATERA. [Internet]. 2018 [cited 2018 Jul 13]. Available from: https://www.natera.com/panorama-test.
   Google Scholar
• Veri SeqTM – NIPT solution by Illumina. [Internet]. 2018 [cited 2018 Jul 13]. Available from: https://www.illumina.com/products/by-type/ivd-products/veriseq-nipt.html.
   Google Scholar
• Harmony® – non-invasive prenatal test by Roche. [Internet]. 2018 [cited 2018 Jul 13]. Available from: https://www.illumina.com/products/by-type/ivd-products/veriseq-nipt.html.
   Google Scholar
• PraenaTest® – non-invasive prenatal test by Lifecodexx. [Internet]. 2018 [cited 2018 Jul 13]. Available from: https://sequencing.roche.com/en/products-solutions/by-application/clinical/nipt.html.
   Google Scholar